Arecor Therapeutics PLC
LSE:AREC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arecor Therapeutics PLC
LSE:AREC
|
UK |
|
P
|
Prologis Inc
F:POJN
|
US |
|
Profilgruppen AB
LSE:0GRO
|
SE |
|
C
|
Cambium Global Timberland Ltd
LSE:TREE
|
JE |
|
Cogent Biosciences Inc
NASDAQ:COGT
|
US |
|
Reliance Steel & Aluminum Co
NYSE:RS
|
US |
|
BROOKFIELD ASSET MANAGEMENT LTD
F:RW5
|
US |
|
Smartsheet Inc
NYSE:SMAR
|
US |
|
Kenedix Office Investment Corp
TSE:8972
|
JP |
|
H
|
Hunan Copote Science Technology Co Ltd
SSE:600476
|
CN |
|
I
|
Innofactor Oyj
OMXH:IFA1V
|
FI |
|
C
|
Cab Payments Holdings PLC
LSE:CABP
|
UK |
|
Lindian Resources Ltd
ASX:LIN
|
AU |
|
C
|
China Sunsine Chemical Holdings Ltd
SGX:QES
|
SG |
|
E
|
Eureka Acquisition Corp
NASDAQ:EURK
|
CN |
Bankruptcy Probability
Arecor Therapeutics PLC's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arecor Therapeutics PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
A
|
Arecor Therapeutics PLC
LSE:AREC
|
25.9m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arecor Therapeutics PLC's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arecor Therapeutics PLC has total debt of 59k GBP. This includes both short-term (0 GBP) and long-term (59k GBP) debt.
You can find a full breakdown on its Balance Sheet.
